The latest online educational activity from Medscape, "Assessing Your Understanding of Key Issues in Hemophilia," became available on Monday, March 23, 2015.
Study finds that men with severe hemophilia A and an inhibitor are at an increased risk of death from bleeding-related complications.
Female carriers of hemophilia and those with mild, moderate and severe hemophilia show early signs of bleeding into joints, according to CDC study.
Lentivirus gene therapy in dogs with hemophilia markedly lowers bleeding rates.
This chapter provides an overview of inhibitors, antibodies to factor product, including the causes and conditions underlying this complication.
Researchers use bio-engineered lettuce leaves to deliver high volumes of factor IX in dogs with hemophilia.
Check out the new PDF available for the Nurses' Guide to Bleeding Disorders chapter, "von Willebrand Disease."
Gene therapy study on 10 patients with severe hemophilia B proves successful now with 3 years worth of data.
New all-oral HCV drug combination is free of ribavirin and interferon.
Read more about PNS, treatments and VWD guidelines.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car